The Tromsø Study, conducted in Tromsø, North Norway, is one of the most renowned and extensive population-based health research initiatives in the world. It was first initiated in 1974 and has since grown into a multi-generational, longitudinal study that has provided invaluable insights into various aspects of public health. The study is primarily led by the University of Tromsø - The Arctic University of Norway, and it has played a pivotal role in shaping health policies and improving healthcare not only in Norway but also globally.
The Tromsø Study has had several waves, with the latest, Tromsø 7, conducted in 2015-2016, gathering data from over 32,000 participants. It covers a wide range of health-related topics, including cardiovascular health, cancer, nutrition, lifestyle, genetics, and more. This comprehensive approach enables researchers to investigate the complex interplay of various factors in the health and well-being of the population.
The Tromsø Study's unique aspect is its focus on the challenges and health conditions faced by the people living in the Arctic regions. Given the unique environmental and lifestyle factors of the area, this study has led to specific insights that are valuable both regionally and internationally. Researchers and healthcare practitioners worldwide have benefitted from the data and findings generated by the Tromsø Study, which continues to be a cornerstone in epidemiological research.
The research projects within the IPSUM study in Tromsø delve into the proper utilization of medications. This encompasses aspects such as the necessity of medication information for users, individuals' beliefs regarding medicines, and the precise targeting of medication information to the relevant patient demographic.